CAEX
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
07/24/2026
Back to search
Official data from USPTO
GENERICBID
This trademark appears in the official USPTO history.
Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9Type: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Case type
Application and registration
Recorded events
38
Latest update
08/18/2026
Trademark type
Combined
Nice classes
35
Filing date
07/02/2014
Registration date
01/12/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/24/2026
Last transaction
08/18/2026
Responsible office
United States Patent and Trademark Office
Status code
710
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/20/2014
First use in commerce
01/05/2015
Drawing code
3
Owner type
16
Owner location
ROCHESTER HILLS, MI, US
Examiner
MIZELLE HOWARD, DEZMONA JULYE
Law office
M10
Current location
TMO LAW OFFICE 110
Mark description
The mark consists of the literal element "GENERICBID", the letters string "GENERIC" in bold with an opened capsule above the letter "i" and round shapes reaching between the "i" and the open capsule.
Holders and representatives
Holders
AUBURN PHARMACEUTICAL, LLC
AUBURN PHARMACEUTICAL COMPANY
AUBURN PHARMACEUTICAL COMPANY
Representatives
Robyn S. Lederman BROOKS KUSHMAN P.C.
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Arranging and conducting auctions in the field of PHARMACEUTICALS; On-line auction services; Providing advertisingmarketing and promotional services for the pharmaceutical and medical products of others; Providing internet auction services via A WEBSITE AND MOBILE APPLICATIONS
Publications
History of USPTO decisions and trademark events.
38 publications found
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/12/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/04/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/07/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/07/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/07/2021
E815
TEAS SECTION 8 & 15 RECEIVED
06/28/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/12/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/12/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/27/2015
PUBO
PUBLISHED FOR OPPOSITION
10/27/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/07/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/21/2015
ALIE
ASSIGNED TO LIE
09/21/2015
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
08/26/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/25/2015
IUAA
USE AMENDMENT ACCEPTED
08/25/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/25/2015
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
07/25/2015
IUAF
USE AMENDMENT FILED
07/25/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/24/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/24/2015
EAAU
TEAS AMENDMENT OF USE RECEIVED
07/24/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/03/2015
GNFR
FINAL REFUSAL E-MAILED
04/03/2015
CNFR
FINAL REFUSAL WRITTEN
04/03/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/17/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/16/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/16/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/20/2014
GNRT
NON-FINAL ACTION E-MAILED
10/20/2014
CNRT
NON-FINAL ACTION WRITTEN
10/20/2014
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/20/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/20/2014
DOCK
ASSIGNED TO EXAMINER
10/11/2014
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/10/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/09/2014
NWAP
NEW APPLICATION ENTERED
07/05/2014
Continuous trademark protection
Get notified about every new filing that threatens GENERICBID or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.